Case Report - Psoriasis
Case Report - Psoriasis
Case Report - Psoriasis
Theresia Monica Rahardjo1, Peter Nugraha Soekmadji1, Epi Panjaitan1, Liyenka Belusi Tantra2, Nathalia
Gabriella2, Stephanie Astrid Gunawan2, Nabilla Aisya Zhavira2
1
Unggul Karsa Medika Teaching Hospital, Bandung
2
Faculty of Medicine, Maranatha Christian University, Bandung
Abstract
Case Report : A 33 year-old male came to Unggul Karsa Medika Hospital’s outpatient
department with itchy, scaly, red plaques all over his body except his palms, soles, and face.
The patient went to the dermatologist because his symptoms were getting worse and worse.
Dermatologic examination conclude the lesions as multiple, generalized, discrete, circumscript,
elevated, dry, regular-discoid erythematous plaques with psoriasiform scales located at the
patient’s head, ears, nape, back, chest, belly, both arms and legs.
Conclusion :The diagnosis of psoriasis vulgaris was made based on history and clinical
symptoms, supported by histopathological results.Treatment optimization and transitioning for
moderate-to-severe plaque psoriasis include methotrexate or cyclosporine, along with topical
therapy and supportive therapy.
Case Report
prognosis
Although psoriasis is just a minor
irritation for some people, it can have a
significant impact on quality of life for
those more severely affected For
example, some people with psoriasis have
low self-esteem because of the effect the
condition has on their appearance. It's
also quite common to develop tenderness,
pain and swelling in the joints and
connective tissue. This is known as
psoriatic arthritis.11
Conclusion
The diagnosis of psoriasis vulgaris
was made based on history and clinical
symptoms, supported by histopathological
results. Psoriasis remains a treatable but
so far not curable disease. Psoriasis is a
chronic condition that is known to have a
negative impact on the quality of life in
patients as well as a family members. The
use of highly effective topical
corticosteroids, the amount, frequency,
and duration of the application, the
structure and the area of the affected skin,
and the application of steroids with
absorbent clothing were among the main
risk factors for the development of
Iatrogenic Cushing’s syndrome (ICS) after
topical steroid use. The patient should be
told to eat healthily, exercise regularly,
and maintain a healthy weight. Treatment
optimization and transitioning for
Reference
1. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci.
2019;20(6):1–28.
2. Jacquiline Habashy, DO, MSc Resident Physician, Department of Dermatology WU of
HSC of OM of the P. Psoriasis.
3. Psoriasis. Nair PA BT
4. Psoriasis P, Dan V, Sjahrir M, Effendy E, Mahadi IDR, Universitas FK, et al. Artikel
Asli. (17):13–7.
5. TNA., Jacoeb seven. MS. Ilmu Penyakit Kulit dan Kelamin. 2021.
6. Perdoksi. PANDUAN PRAKTIK KLINIS. 2017.
7. Jacobs T, Kgokolo CM. Treatment of psoriasis. SA Pharm J. 2021;88(1):23–6.
8. Tveit KS. Diagnosis and management of psoriasis. Nord Congr Dermatology
Venereol. 2019;63(April):278–85.
9. Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the
development of psoriasis. Int J Mol Sci. 2019;20(18):1–14.
10. Raharja A, Mahil SK, Barker JN. Psoriasis: A brief overview. Clin Med J R Coll
Physicians London. 2021;21(3):170–3.
11. Psoriasis. NHS.
12. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al.
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3.
Guidelines of care for the management and treatment of psoriasis with topical
therapies. J Am Acad Dermatol. 2009;60(4):643–59.
13. Papp K, Gulliver W, Lynde C, Poulin Y, Ashkenas J. Canadian guidelines for the
management of plaque psoriasis: Overview. J Cutan Med Surg. 2011;15(4):210–9.
14. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and
hypertension: A prospective study of us female nurses. Arch Dermatol.
2009;145(4):379–82.
15. Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, et al. Consensus
conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis. J
Am Acad Dermatol. 2001;45(4):544–53.
16. G. M, H.-J. S, M. B, P. M, R. S, E.G. J, et al. Anti-inflammatory efficacy of low-dose
cyclosporin A in psoriatic arthritis. A prospective multicentre study. Br J Dermatol.
1996;135(5):752–7.
17. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al.
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1.
Overview of psoriasis and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol. 2008;58(5):826–50.
18. Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM. The risk of
infection and malignancy with tumor necrosis factor antagonists in adults with
psoriatic disease: A systematic review and meta-analysis of randomized controlled
trials. J Am Acad Dermatol. 2011;64(6):1035–50.
19. Zhang XJ, Zhang XB. Guidelines for the Diagnosis and Treatment of Psoriasis in
China: 2019 Concise Edition#. Int J Dermatology Venereol. 2021;14–26.